Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,917
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Dallas TX, Baton Rouge LA, St Louis MO,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07170917
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Assessing the Functional Movement Screen as a Reliable Physical Therapy Discharge Criteria for Chronic Lower Back Pain Patients
for
Chronic Lower Back Pain
Location: Plano TX
Sponsor: Texas Back Institute
Sex: All
Age: 18 - 49
Code: NCT06474429
Recruiting
Gait and Balance in Thoracolumbar Spinal Deformity
for
Spinal Curvatures
Location: Plano TX
Sponsor: Texas Back Institute
Sex: All
Age: 30+
Code: NCT02761265
Recruiting
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
for
Aortic Arch Aneurysm, Aortic Arch Dissection,
Location: Plano TX, Austin TX, Houston TX, Birmingham AL,
Sponsor: Artivion Inc.
Sex: All
Age: 18 - 70+
Code: NCT07089576
Recruiting
Tailored Exercise Training Study Among Adults With HFpEF
for
HFpEF - Heart Failure With Preserved Ejection Fraction,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT07223242
Phase2, Phase3, Recruiting
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
for
Schizophrenia
Location: Richardson TX, Austin TX, Oklahoma City OK,
Sponsor: Reviva Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT05184335
Phase3, Recruiting
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
for
Bipolar Disorder
Location: Richardson TX, McKinney TX, Waterloo IA, Atlanta GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07286175
Phase2, Recruiting
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
for
Schizophrenia
Location: Richardson TX, Austin TX, Atlanta GA, Chicago IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 55
Code: NCT07615426
Phase1, Recruiting
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
for
Schizophrenia
Location: Richardson TX, Little Rock AR, Decatur GA, DeLand FL,
Sponsor: Leal Therapeutics, Inc
Sex: All
Age: 18 - 55
Code: NCT07734493
Phase1, Recruiting
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
for
Major Depressive Disorder
Location: Richardson TX, Houston TX, Overland Park KS,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 18 - 65
Code: NCT05850689
Phase3, Recruiting
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
for
Schizophrenia
Location: Richardson TX, Austin TX, Rogers AR, Little Rock AR,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18 - 65
Code: NCT06894212
Phase3, Recruiting
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
for
Neonatal Hypoglycemia
Location: McKinney TX
Sponsor: Baylor Research Institute
Sex: All
Age: 0
Code: NCT07217483
Recruiting
New
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
for
Schizophrenia
Location: Richardson TX, Bentonville AR, Little Rock AR,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 18 - 65
Code: NCT07686263
Phase3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: DeSoto TX, Dallas TX, Carrollton TX, Allen TX,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype